Medicare Enrolled
Dr. Maria Mascolo, MD
Pulmonary Disease · Rincon, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mascolo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mascolo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mascolo
Dr. Maria Mascolo is a pulmonary disease specialist in Rincon, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mascolo performed 4,779 Medicare services across 2,843 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mascolo received a total of $238,194 from 49 pharmaceutical and/or device companies across 1208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mascolo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in GA
$238,194 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,779
Medicare services
Top 2% in GA for pulmonary disease
2,843
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~239 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
871 | $88 | $137 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
808 | $0 | $2 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
596 | $62 | $111 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
505 | $19 | $36 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
315 | $30 | $44 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
315 | $38 | $61 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
216 | $0 | $21 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
155 | $10 | $14 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
152 | $27 | $47 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
149 | $35 | $54 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
105 | $87 | $121 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
101 | $62 | $85 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
100 | $24 | $33 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
91 | $113 | $178 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
83 | $17 | $26 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
58 | $27 | $30 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $78 | $111 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
33 | $416 | $566 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
30 | $100 | $155 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
28 | $37 | $55 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $128 | $186 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $135 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$238,194
Total received (2018-2024)
Avg $34,028/year across 7 years
Top 1% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
1,208
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$218,939 (91.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,114 (6.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,141 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$90,911
2023
$102,979
2022
$29,032
2021
$9,624
2020
$1,668
2019
$2,377
2018
$1,604
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$88,601
GENZYME CORPORATION
$399
Regeneron Healthcare Solutions, Inc.
$334
GlaxoSmithKline, LLC.
$252
Grifols USA, LLC
$153
HARMONY BIOSCIENCES LLC
$151
Insmed, Inc.
$148
Mylan Specialty L.P.
$133
Amgen Inc.
$110
United Therapeutics Corporation
$97
ANI Pharmaceuticals, Inc.
$84
Merck Sharp & Dohme LLC
$83
Actelion Pharmaceuticals US, Inc.
$75
Axsome Therapeutics, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$59
Philips North America LLC
$50
Electromed, Inc.
$28
Baxter Healthcare
$23
Takeda Pharmaceuticals U.S.A., Inc.
$19
PFIZER INC.
$18
Avadel CNS Pharmaceuticals, LLC
$14
Harmony Biosciences Llc
$10
Top 3 companies account for 98.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$200,835
Amgen Inc.
$18,673
GENZYME CORPORATION
$4,749
GlaxoSmithKline, LLC.
$2,574
Regeneron Healthcare Solutions, Inc.
$1,270
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,217
Grifols USA, LLC
$910
Insmed, Inc.
$766
Mylan Specialty L.P.
$752
Electromed, Inc.
$709
Actelion Pharmaceuticals US, Inc.
$682
United Therapeutics Corporation
$562
Mallinckrodt Hospital Products Inc.
$516
JAZZ PHARMACEUTICALS INC.
$375
Axsome Therapeutics, Inc.
$366
Philips Electronics North America Corporation
$344
Harmony Biosciences LLC
$290
Merck Sharp & Dohme LLC
$273
Takeda Pharmaceuticals U.S.A., Inc.
$233
HARMONY BIOSCIENCES LLC
$193
Jazz Pharmaceuticals Inc.
$185
Sunovion Pharmaceuticals Inc.
$167
Teva Pharmaceuticals USA, Inc.
$162
Circassia Pharmaceuticals Inc
$152
Shire North American Group Inc
$102
Eisai Inc.
$86
Genentech USA, Inc.
$85
ANI Pharmaceuticals, Inc.
$84
Mallinckrodt Enterprises LLC
$83
Merck Sharp & Dohme Corporation
$82
Allergan Inc.
$70
Bayer HealthCare Pharmaceuticals Inc.
$65
Advanced Respiratory, Inc
$61
Fisher & Paykel Healthcare Inc
$60
Philips North America LLC
$50
PFIZER INC.
$50
Gilead Sciences, Inc.
$48
Baxter Healthcare
$45
Novartis Pharmaceuticals Corporation
$37
Inogen, Inc.
$32
Allergan, Inc.
$32
EISAI INC.
$31
Mallinckrodt LLC
$31
Janssen Pharmaceuticals, Inc
$29
Inspire Medical Systems, Inc.
$25
Avadel CNS Pharmaceuticals, LLC
$14
IDORSIA PHARMACEUTICALS US INC
$14
CSL Behring
$13
Harmony Biosciences Llc
$10
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
(8874) InCourage · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BOSENTAN TABLETS · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHANTIX · CINQAIR · DALVANCE · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Vest System Model 105 Home Care · Hizentra · INOGEN · INSPIRE · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PREVNAR 20 · PT100US/myAIRVO 2 · PURIFIED CORTROPHIN GEL · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON · Utibron · WAKIX · WINREVAIR · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pulmonary disease in GA.
Geographic Context
Pulmonary diseases within 10 mi
13
Per 100K population
19.3
County median income
$85,465
Nearest hospital
COASTAL CAROLINA HOSPITAL
10.3 mi
10.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mascolo is a clinical cardiology specialist, with above-average Medicare volume (top 2% in GA), with speaking/promotional industry engagement in the top 1% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mascolo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mascolo performed 871 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mascolo receive payments from pharmaceutical companies?
Yes. Dr. Mascolo received a total of $238,194 from 49 companies across 1,208 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mascolo's costs compare to other pulmonary diseases in Rincon?
Dr. Mascolo's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mascolo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Rincon
Browse pulmonary diseases in Rincon ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology